Regeneron Pharmaceuticals
REGN
REGN
813 hedge funds and large institutions have $36.9B invested in Regeneron Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 198 funds opening new positions, 280 increasing their positions, 254 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
813
Holders Change
+112
Holders Change %
+15.98%
% of All Funds
17.96%
Holding in Top 10
22
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+37.5%
% of All Funds
0.49%
New
198
Increased
280
Reduced
254
Closed
79
Calls
$1.04B
Puts
$959M
Net Calls
+$83.4M
Net Calls Change
+$234M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.56B |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$233M |
| 3 |
BlackRock
New York
|
+$224M |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$209M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$106M |
Top Sellers
| 1 |
Harris Associates
Chicago,
Illinois
|
-$1B |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$586M |
| 3 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
-$288M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$182M |
| 5 |
HM
HealthCor Management
New York
|
-$140M |
